Bonum Therapeutics

0 followers


Bonum Therapeutics is creating a technology platform that can be used to treat a wide range of diseases, including cancer which is the company’s primary therapeutic area of focus—as well as metabolic diseases, immunology, and pain management.

Industries

+1

Headquarters

Stage

Employees

Links

John Mulligan, Ph.D.
Founder and CEO

John Mulligan, Ph.D.

Collapse
Cindy Lai Yee
Head of Portfolio Strategy & Operations
David Bienvenue
Senior Director, Protein Sciences
Justin Killebrew
Senior Director, Immuno-Oncology Discovery